The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A comprehensive survey of tumor mutation burden (TMB) using the AACR GENIE cbioportal database: Pathogenesis of NTRK and RET fusion (NTRK+/RET+) positive colorectal (CRC).
 
Zhaohui Arter
No Relationships to Disclose
 
Alexandria TM Lee
No Relationships to Disclose
 
Misako Nagasaka
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Daiichi Sankyo; EMD Serono; Genentech; Janssen; Lilly; Mirati Therapeutics; Novartis; Pfizer; Takeda
Speakers' Bureau - Blueprint Medicines; Janssen; Mirati Therapeutics; Mirati Therapeutics; Takeda
Research Funding - Tempus
Travel, Accommodations, Expenses - Anheart Therapeutics
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - Elevation Oncology; Turning Point Therapeutics
Honoraria - DAVA Oncology LLP; JNJ Jassen; Pfizer
Consulting or Advisory Role - Anheart Therapeutics; BeiGene; Lilly
Speakers' Bureau - JNJ Janssen; Pfizer
Research Funding - BMS Brazil (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Revolution Medicines (Inst)